SenesTech, Inc. (NASDAQ:SNES) Files An 8-K Regulation FD Disclosure
Item7.01
| Regulation FD Disclosure. |
On June 19, 2017, SenesTech, Inc. (the Company) sent a letter to
the Companys pre-IPO stockholders. A copy of the stockholder
letter dated June 19, 2017 is furnished with this report as
Exhibit 99.1, and is incorporated herein by reference.
| Item9.01 | Financial Statements and Exhibits. |
| (d) | Exhibits. |
|
ExhibitNo. |
Description | |
| 99.1 | Stockholder letter dated June 19, 2017* | |
________
* This exhibit is intended to be furnished and shall not be
deemed filed for purposes of the Securities Exchange Act of 1934,
as amended.
About SenesTech, Inc. (NASDAQ:SNES)
SenesTech, Inc. is a platform biotechnology company. The Company is engaged in developing a technology for managing animal pest populations through fertility control. Its approach is designed to manage food security and manage infrastructure damage, disease outbreaks, environmental contamination and other costs associated with rodent infestations. Its fertility control product candidate, ContraPest, will be marketed for use in controlling rat populations. ContraPest targets the reproductive capabilities of rodents by inducing the gradual loss of eggs in female rodents and disruption of sperm in male rodents, resulting in contraception that can progress to sterility in both females and males. The Company applies its technology to manage rats in urban and agricultural settings. It has a pipeline of fertility control and animal health products, which include ContraPest, Plant-based fertility control, Feral animal fertility control, Boar taint, and Non-Surgical Spay and Neutering.
